Financials
- Market Capitalization 8.07 M
- Employee 8
- Founded 2017
- CEO N/A
- Website www.cnspharma.com
- Headquarter Nevada, United States
- FIGI BBG00PM24T16
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.15
ratio cours/chiffre d'affaires
-909.61
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4810 | XCUR Exicure, Inc. - Common Stock | 1.29 USD | -8.51% | +9.32% | -25.86% | -75.57% | 8.44 M USD | ||
| 4814 | SNGX Soligenix, Inc. - Common Stock | 0.38 USD | 0.00% | -7.32% | +2.70% | -66.37% | 8.27 M USD | ||
| 4821 | ALZN Alzamend Neuro, Inc. - Common Stock | 1.66 USD | -0.60% | +9.93% | +24.81% | -32.52% | 7.95 M USD | ||
| 4823 | AIM AIM ImmunoTech Inc. Common Stock | 0.26 USD | +4.00% | 0.00% | +8.33% | -89.65% | 7.91 M USD |